Joe Park is a seasoned healthcare and business leader with over 20 years of experience involving life sciences, corporate development, and venture capital. He holds a MBA from Columbia Business School. Joe played a pivotal role when Modifi Bio was acquired by Merck & Co. for 1.3B on Oct 2024.
Paul Kwak is a seasoned healthcare, defense, and enterprise AI executive with over 20 years of leadership experience across life sciences, corporate development, and federal innovation. He currently serves as Senior Director of Strategic Solutions at C3 AI, where he leads enterprise AI initiatives for national security and healthcare stak
Paul Kwak is a seasoned healthcare, defense, and enterprise AI executive with over 20 years of leadership experience across life sciences, corporate development, and federal innovation. He currently serves as Senior Director of Strategic Solutions at C3 AI, where he leads enterprise AI initiatives for national security and healthcare stakeholders. Prior to that, Paul led data and analytics programs at Technomics and Group W, supporting U.S. Department of Defense and federal civilian agencies.
Natalia is an emerging leader in impact investing, venture capital, and financial strategy, with a strong focus on sustainable investments and innovative business models. She holds a background in finance and investment analysis, having worked with global firms on market research, strategic investments, and ESG-focused financial initiatives.
Copyright © 2025 FELPEL VENTURES - All Rights Reserved.
We use cookies to analyze website traffic and optimize your website experience. By accepting our use of cookies, your data will be aggregated with all other user data.